Weifeng Hong

机构：Youjiang Medical College for Nationalities, Zhejiang Cancer Hospital, Zhongshan Hospital of Xiamen University · ORCID：0000-0001-6640-2537

发表论文 59 篇 · 总被引 1456 次 · h-index 18

代表论文

• A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade (2024 · Nature Communications · 被引 40)
• Lactylation: The metabolic accomplice shaping cancer's response to radiotherapy and immunotherapy (2025 · Ageing Research Reviews · 被引 30)
• CEA-induced PI3K/AKT pathway activation through the binding of CEA to KRT1 contributes to oxaliplatin resistance in gastric cancer (2024 · Drug Resistance Updates · 被引 24)
• Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy (2025 · Molecular Cancer · 被引 17)
• Application of spatial and single-cell omics in tumor immunotherapy biomarkers (2025 · LabMed discovery. · 被引 16)
• RRM2‐targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling (2025 · iMeta · 被引 14)